Samsung Electronics and Medtronic are teaming up to develop mobile
apps to provide insight and access on diabetes data, including glucose
monitoring information, for Medtronic's MiniMed Connect. The MiniMed
Connect device offers providers faster and easier
access to patient insulin pump and glucose data in a mobile
environment, as well as remote alerts, which Medtronic says will allow
for more real-time care plan adjustment capability.
The U.S. Food and Drug Administration-approved Connect device lets
diabetics view insulin pump and glucose monitor data on a smartphone,
and provides remote monitoring and text messages for caregivers.
Medtronic will also be
working with Glooko, which has a cloud-based diabetes management platform.
The Medtronic-Glooko partnership will allow Medtronic to integrate
other health and wellness data sources, such as food, medication,
fitness and biometric data with its CareLink platform. This data,
combined with insight via the Connect diabetes data, will
help patients manage the chronic condition.
For further information, click here.
No comments:
Post a Comment